Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 1

Active, not recruiting

Conditions: Metastatic Pancreatic Carcinoma
Pancreatic Carcinoma
Pancreatic Carcinoma Non-resectable
Pancreatic Cancer
Pancreatic Cancer Metastatic
PDAC - Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer Non-resectable
PDAC

Interventions: Drug: Pertzye

First Posted Date: 2022-12-08

Last Posted Date: 2025-05-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 17

Registration Number: NCT05642962

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Not Applicable

Recruiting

Conditions: Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance

Interventions: Other: Placebo supplements
Other: Whole Foods Plant-based Diet
Dietary Supplement: Algae omega 3

First Posted Date: 2022-12-07

Last Posted Date: 2025-03-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 150

Registration Number: NCT05640843

Locations: 🇺🇸
Emory University (Data Collection Only), Atlanta, Georgia, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States

and more 5 locations

A Study of LN-144 in People With Metastatic Melanoma to the Brain

Phase 1

Active, not recruiting

Conditions: Metastatic Melanoma

Interventions: Biological: Lifileucel (LN-144)

First Posted Date: 2022-12-07

Last Posted Date: 2024-10-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT05640193

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of Tooth Erosion in People With Esophagogastric Cancer

Not Applicable

Recruiting

Conditions: Esophagogastric Cancer

Interventions: Other: Survey
Other: Intra-oral camera
Other: Optional Salvia sample

First Posted Date: 2022-11-10

Last Posted Date: 2025-02-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 300

Registration Number: NCT05612048

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of ZEN003694 in People With Squamous Cell Lung Cancer

Phase 2

Recruiting

Conditions: Squamous Cell Lung Cancer

Interventions: Drug: ZEN003694

First Posted Date: 2022-11-07

Last Posted Date: 2024-12-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 25

Registration Number: NCT05607108

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

Phase 1

Recruiting

Conditions: Uveal Melanoma
Melanoma
Metastatic Melanoma
Metastatic Uveal Melanoma

Interventions: Biological: Lifileucel (LN-144/LN-145)

First Posted Date: 2022-11-07

Last Posted Date: 2025-05-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT05607095

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

Recruiting

Conditions: Breast Cancer

Interventions: Other: Physical Evaluation
Diagnostic Test: Dual-energy X-ray absorptiometry scans
Diagnostic Test: Trabecular Bone Score

First Posted Date: 2022-10-21

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 100

Registration Number: NCT05590949

Locations: 🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack, New York, United States

and more 4 locations

A Study of the EMPOWER Program for Latinx Caregivers of ICU Patients

Not Applicable

Withdrawn

Conditions: Informal Caregiver

Interventions: Behavioral: EMPOWER-Latinx

First Posted Date: 2022-10-21

Last Posted Date: 2023-11-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT05589883

A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma

Phase 1

Active, not recruiting

Conditions: Non-Hodgkin Lymphoma
Non-Hodgkin's Lymphoma, Relapsed
Non-Hodgkin's Lymphoma Refractory

Interventions: Radiation: Bridging radiotherapy (BRT)
Drug: Conditioning chemotherapy
Biological: CAR T-cell product

First Posted Date: 2022-10-10

Last Posted Date: 2024-12-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT05574114

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Phase 2

Active, not recruiting

Conditions: Cutaneous Squamous Cell Carcinoma
Skin Cancer
Squamous Cell Carcinoma
Locally Advanced Squamous Cell Carcinoma
Locally Advanced Squamous Cell Carcinoma of the Skin
Locally Advanced Cutaneous Squamous Cell Carcinoma
Locally Advanced Skin Squamous Cell Carcinoma

Interventions: Drug: Cemiplimab
Radiation: Radiotherapy

First Posted Date: 2022-10-10

Last Posted Date: 2025-05-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 34

Registration Number: NCT05574101

Locations: 🇺🇸
University of Colorado (Data Collection Only), Aurora, Colorado, United States
🇺🇸
Moffitt Cancer Center (Data Collection Only), Tampa, Florida, United States
🇺🇸
Memorial Sloan Kettering Cancer Center at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

and more 10 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy